Security Check

Guangzhou Royal Lee Cancer Center

JCI Accredited International Tertiary Cancer Specialty Hospital
Top Specialties
HPB Oncology
Guangdong's first "one-stop" standardized HPB treatment benchmark.
Minimally Invasive Oncology
Advanced therapies including Y-90, Nanoknife, and Argon-Helium Cryoablation.
Super-Platform MDT
Gathering 100+ top oncology experts domestically and internationally.
Hospital Introduction
Guangzhou Royal Lee Cancer Center is an international tertiary cancer specialty hospital, solely invested by the Royal Lee (Thailand) International Group. Located in the Sino-Singapore Guangzhou Knowledge City, it pioneers a "Super Platform-Type" oncology service model, integrating cutting-edge minimally invasive therapies with full-process tumor management.
JCI Accredited
GCP Certified Institution
Tertiary Specialty Hospital
Global Insurance Partnerships
Book Consultation
Hospital Tier
Tertiary Grade-A
Ownership
Private Hospital
Location
Guangzhou, China
Established
2020
Address
No.1 Ciji Road, Sino-Singapore Knowledge City
Guangzhou Royal Lee Cancer Center
No.1 Ciji Road, Sino-Singapore Knowledge City
Guangzhou, Guangdong, China
400 Total Open Beds
106000 Total Area (m²)
6 Advanced Operating Rooms
40 Commercial Insurance Partners

Key Insight: The center boasts 12 clinical departments and 7 medical technology departments, equipped with Class 100 and Class 10,000 laminar flow operating rooms as well as a specialized hybrid operating suite.

A Global Benchmark in
Precision Oncology Care

Guangzhou Royal Lee Cancer Center represents a paradigm shift in cancer care, operating as a "Super Platform-Type" medical institution. By breaking through traditional single-department models, it unites top-tier multidisciplinary experts to deliver scientifically accurate, individualized treatment plans.

The facility seamlessly integrates sophisticated minimally invasive techniques, such as Y-90 and Proton Therapy, with holistic palliative care encompassing nutrition, psychology, and TCM approaches, ensuring comprehensive lifecycle management for global cancer patients.

Host Unit

National Drug Clinical Trial Institution

GI Tumor Diagnosis & Treatment Center
South China's Largest Palliative Center

Hospital Classification & Innovation Model

JCI

International Safety Standards

As a privately invested, foreign-funded tertiary cancer specialty hospital, the center operates outside the traditional public hospital ranking systems, driven instead by its JCI accreditation and innovative "Super Platform-Type" collaborative model.

Institutional Status & External Evidence

Ranking / External Evaluation
JCI International Hospital Accreditation
Hospital Classification / Accreditation
GSP (Good Supply Practice) Certification National Medical Insurance Designated Institution Guangdong Province Modern Industry Top 500 Project Guangzhou "Three Major Breakthroughs" Project
National Designations / Academic Indicators
National Tertiary Cancer Specialty Hospital National Drug Clinical Trial Institution (GCP)

Core Featured Specialties

Hepatobiliary-Pancreatic (HPB) Oncology

Guangdong's first benchmark for standardized "one-stop" HPB tumor treatment, co-established with Boji Renyi Medical Group.

Minimally Invasive Oncology

Providing advanced Y-90, Nanoknife (IRE), Argon-Helium Cryoablation, and Brachytherapy Seed Implantation.

Breast Oncology Center

Delivering multidisciplinary breast cancer treatment, breast-conserving surgery, and comprehensive rehabilitation.

GI Tumor Diagnosis & Treatment

Precision MDT platform for gastric, colorectal, and esophageal cancers in partnership with SYSU Cancer Center.

Palliative Oncology Center

The largest of its kind in South China, offering premier pain management, nutrition, and hospice care.

Gynecologic Oncology Center

Specialized multidisciplinary interventions for cervical, ovarian, and endometrial malignancies.

Medical & Research Innovation Hubs

National Drug Clinical Trial Institution (GCP Base)
MDT Multi-Disciplinary Consultation Platform (with SYSUCC)
Royal Lee-Boji Renyi HPB Oncology Specialty
GI Tumor Diagnosis & Treatment Center
Body Surface Tumor Center
Minimally Invasive Oncology Center
South China's Largest Palliative Oncology Center
Oncology Health Management Center

Global Oncology Services & VIP Care

Operating as a fully internationalized healthcare institution, Guangzhou Royal Lee Cancer Center seamlessly integrates global medical standards without the need for a separate "International Department." The hospital holds deep partnerships with Mayo Clinic, Massachusetts International Medical Group, and over 40 global commercial insurance companies.

  • Multilingual medical team providing overseas telemedicine consultations and international two-way referrals.
  • Meticulous end-to-end VIP transportation from airports and train stations with dedicated translation support.
  • Respecting diverse religious beliefs by providing on-site mosques, Buddhist halls, and prayer rooms.

Global Excellence Standard

By bridging international physician team residencies and strict JCI protocols, the center guarantees a superior, secure, and culturally respectful healing environment for patients worldwide.

Integrated Health Management

Featuring comprehensive in-stay physical examinations and full lifecycle management for early cancer screening and prevention.

Source & Verification

Hospital entity information on this page is maintained from official institutional and government-level sources reviewed by MedBridge. Departmental services, rankings, certifications, and operational information may change over time and should be confirmed with the institution before making a medical decision.

Primary Institutional Source Guangzhou Royal Lee Cancer Center — official hospital website.
Government / Official Records Chinese government and official institutional records reviewed as part of the MedBridge audit process.
MedBridge Verification Hospital entity data has been reviewed against the source records maintained by MedBridge.
QA date: October 6, 2026.